Comparison of plateletpheresis on three continuous flow cell separators

Tendulkar, Anita; Rajadhyaksha, Sunil B.
July 2009
Asian Journal of Transfusion Science;Jul-Dec2009, Vol. 3 Issue 2, p73
Academic Journal
Introduction: Platelet concentrate (PC) remains one of the most important support measures in thrombocytopenic patients. An efficient cell separator is a prerequisite for an optimally functioning apheresis setup. Donor blood count may undergo a temporary reduction after the procedure. Aim: The aim was to find the extent of reduction in donor blood count (hemoglobin, hematocrit, white blood cell, and platelet) after plateletpheresis and to evaluate the cell separator for collection efficiency, processing time, and leukoreduction. Study Design and Methods: Two hundred and thirty seven procedures performed on the Amicus (N = 121), Fenwal CS-3000 Plus (N = 50) and Cobe spectra (N = 66) in a one year period were evaluated. The procedures performed on the continuous flow centrifugation (CFC) cell separators and donor blood counts (pre and post donation) done were included in the study. Results: The percent reduction in hemoglobin (HB), hematocrit (HCT), white blood cell (WBC) and platelet count ((PLT ct) was 2.9, 3.1, 9, 30.7 (Mean, N = 237) respectively after the procedure. The post donation PLT ct reduced to <100x109/L (range 80-100) in five donors (N = 5/237, Amicus). The pre donation PLT ct in them was 150-200x109/L. Collection efficiency (percent) of Amicus (79.3) was better as compared to the other two machines (CS: 62.5, Cobe: 57.5). PC collected on Cobe spectra had <1x106 WBC. The donor pre donation PLT levels had a positive correlation to the product PLT yield (r = 0.30, P = 0.000). Conclusion: Monitoring donor blood counts helps to avoid pheresis induced adverse events. A cautious approach is necessary in donors whose pre donation PLT ct is 150-200x109/L. The main variable in PLT yield is donor PLT ct (pre donation). High collection efficiency is a direct measure of an optimally functioning cell separator.


Related Articles

  • Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods. Singh, Ravindra P.; Marwaha, Neelam; Malhotra, Pankaj; Dash, Sumitra // Asian Journal of Transfusion Science;Jul-Dec2009, Vol. 3 Issue 2, p86 

    Background: Platelet rich plasma-platelet concentrate (PRP-PC), buffy coat poor-platelet concentrate (BC-PC), and apheresis- PC were prepared and their quality parameters were assessed. Study Design: In this study, the following platelet products were prepared: from random donor platelets (i)...

  • HPA-genotyping and antiplatelet antibodies in female blood donors. Boehlen, Fran├žoise; Bulla, Oana; Michel, Martine; Reber, Guido; de Moerloose, Philippe // Hematology Journal;2003, Vol. 4 Issue 6, p441 

    Cases of passive alloimmune thrombocytopenia have been reported due to transfusions of blood products with antiplatelet antibodies. The aim of our study was to search for antiplatelet antibodies in HPA-homozygous blood donor women once pregnant and also to perform, in case of positivity, a...

  • THE EFFECT OF LONG-TERM REGULAR PLATELETPHERESIS ON DONOR PLATELET COUNTS. M., Rapiaah; T. M., Roshan; L., Naing; A., Rehman; S. A., Ahmed; H., Roslin; S. H., Lim // Malaysian Journal of Medical Sciences;Jan2007 Supplement, Vol. 14, p122 

    Introduction: Plateletpheresis is used to obtain large numbers of platelets from random volunteer donors. One unit of plateletapheresis is equal to 4 to 6 random donor platelets. Because large numbers of platelet have been collected, transient but significant decreases in donors' platelet counts...

  • HIV SEROPOSITIVITY IN HUSM BLOOD DONORS. M. N., Noor Haslina; B., Rosnah; M. Y., Shafini; W. M., Wan Haslinda // Malaysian Journal of Medical Sciences;Jan2006 Supplement, Vol. 13, p212 

    PURPOSE : Transfusion of HIV continues to be a threat to safe blood transfusion. Developing countries account for more than 90% of all new HIV cases. In Malaysia the number of infected individuals has increased steadily each year. The objective of this study is to assess the prevalence and trend...

  • Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique. Stokx, Jocelijn; Gillet, Philippe; De Weggheleire, Anja; Casas, Esther C.; Maendaenda, Rosa; Beulane, Adelino J.; Jani, Ilhes V.; Kidane, Solon; Mosse, Carla D.; Jacobs, Jan; Bottieau, Emmanuel // BMC Infectious Diseases;2011, Vol. 11 Issue 1, p141 

    Background: The World Health Organization recommends universal and quality-controlled screening of blood donations for the major transfusion-transmissible infections (TTIs): human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis. The study objectives...

  • Assessment of plateletphersis donation in Tehran Blood Center. Chegini, A.; Mirrezaie, M.; Poorreza, M.; Rezaie, A. R.; Anbardan, A. J. // Scientific Journal of Iranian Blood Transfusion Organization;Summer2013, Vol. 10 Issue 2, p140 

    Background and Objectives Additional and more effective platelets can be gained through plateletphersis which at times equals platelets of 8 units of blood. Patients are exposed to a less number of donors through prescription of such platelets. Although side-effects of plateletphersis are low...

  • Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis. Liesveld, J; Pawlowski, J; Chen, R; Hyrien, O; Debolt, J; Becker, M; Phillips, G; Chen, Y // Bone Marrow Transplantation;May2013, Vol. 48 Issue 5, p691 

    Successful utilization of SCT modalities often requires utilization of both red cell and platelet transfusions. In this retrospective evaluation of clinical factors affecting transplant engraftment and transfusion utilization at a single transplant center in 505 patients from 2005 through 2009,...

  • Initial Values of Donor Hematocrit and Efficiency of Plateletpheresis. Landzo, Elvedin; Sofo-Hafizovic, Alma; Cetkovic-Basic, Vesna // Acta Informatica Medica;2013, Vol. 21 Issue 2, p116 

    Introduction: The collection of platelets by apheresis is considered as a very great progress in transfusion medicine. A larger yield (total number of collected plateiets) is obtained if the donor has a greater number of initial platelets and if the separation is done in a shorter time. One of...

  • Our experience with apheresis platelet transfusion therapy (April 1999-March 2006). Sharma, R. R.; Saluja, K.; Thakral, B.; Bajpai, M.; Sharma, L.; Jain, A.; Hazarika, R.; Marwaha, N. // Asian Journal of Transfusion Science;Jul-Dec2007, Vol. 1 Issue 2, p92 

    Background: Platelet transfusion therapy has dramatically improved clinical outcome in patients with thrombocytopenia, especially in hemato-oncology set-up. This therapy has evolved over the year from the crude method of gravity separation to the present day sophisticated apheresis technology....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics